Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 173

The DOI matches its Crossref record.

Clinical and treatment factors determining long‐term outcomes for adult survivors of childhood low‐grade glioma: A population‐based study

Open access
Krishnatry, Rahul, Zhukova, Nataliya, Guerreiro Stucklin, Ana S., Pole, Jason D., Mistry, Matthew, Fried, Iris, Ramaswamy, Vijay, Bartels, Ute, Huang, Annie, Laperriere, Normand, Dirks, Peter, Nathan, Paul C., Greenberg, Mark, Malkin, David, Hawkins, Cynthia, Bandopadhayay, Pratiti, Kieran, Mark W., Manley, Peter E., Bouffet, Eric, Tabori, Uri · 2016 · Cancer

Abstract

BACKGROUND: The determinants of outcomes for adult survivors of pediatric low‐grade glioma (PLGG) are largely unknown. METHODS: This study collected population‐based follow‐up information for all PLGG patients diagnosed in Ontario, Canada from 1985 to 2012 (n = 1202) and determined factors affecting survival. The impact of upfront radiation treatment on overall survival (OS) was determined for a cohort of Ontario patients and an independent reference cohort from the Surveillance, Epidemiology, and End Results database. RESULTS: At a median follow‐up of 12.73 years (range, 0.02‐33 years), only 93 deaths (7.7%) were recorded, and the 20‐year OS rate was 90.1% ± 1.1%. Children with neurofibromatosis type 1 had excellent survival and no tumor‐related deaths during adulthood. Adverse risk factors included pleomorphic xanthoastrocytoma (P < .001) and a thalamic location (P < .001). For patients with unresectable tumors surviving more than 5 years after the diagnosis, upfront radiotherapy was associated with an approximately 3‐fold increased risk of overall late deaths (hazard ratio [HR], 3.3; 95% confidence interval [CI], 1.6‐6.6; P = .001) and an approximately 4‐fold increased risk of tumor‐related deaths (HR, 4.4; 95% CI, 1.3‐14.6; P = .013). In a multivariate analysis, radiotherapy was the most significant factor associated with late all‐cause deaths (HR, 3.0; 95% CI, 1.3‐7.0; P = .012) and tumor‐related deaths (HR, 4.4; 95% CI, 1.3‐14.6; P = 0.014). A similar association between radiotherapy and late deaths was observed in the independent reference cohort (P < .001). In contrast to early deaths, late mortality was associated not with PLGG progression but rather with tumor transformation and non‐oncological causes. CONCLUSIONS: The course of PLGG is associated with excellent long‐term survival, but this is hampered by increased delayed mortality in patients receiving upfront radiotherapy. These observations should be considered when treatment options are being weighed for these patients. Cancer 2016;122:1261–9. © 2016 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.29907

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 173

Metadata

Authors
Krishnatry, R., Zhukova, N., Guerreiro Stucklin, A. S., Pole, J. D., Mistry, M., Fried, I., Ramaswamy, V., Bartels, U., Huang, A., Laperriere, N., Dirks, P., Nathan, P. C., Greenberg, M., Malkin, D., Hawkins, C., Bandopadhayay, P., Kieran, M. W., Manley, P. E., Bouffet, E., & Tabori, U.
Venue
Cancer
Publisher
Wiley
Published
2016-03-10
Volume
122
Issue
8
Pages
1261-1269
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2296203480
Cited by
173
References
0
FWCI
8.91
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical and treatment factors determining long‐term outcomes for adult survivors of childhood low‐grade glioma: A population‐based study. https://app.cochat.ai/papers/10.1002/cncr.29907
The paper
Krishnatry, R., Zhukova, N., Guerreiro Stucklin, A. S., Pole, J. D., Mistry, M., Fried, I., Ramaswamy, V., Bartels, U., Huang, A., Laperriere, N., Dirks, P., Nathan, P. C., Greenberg, M., Malkin, D., Hawkins, C., Bandopadhayay, P., Kieran, M. W., Manley, P. E., Bouffet, E., & Tabori, U. (2016). Clinical and treatment factors determining long‐term outcomes for adult survivors of childhood low‐grade glioma: A population‐based study. Cancer. https://doi.org/10.1002/cncr.29907

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.